337 related articles for article (PubMed ID: 10336422)
21. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
22. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARgamma in induction of differentiation and apoptosis of S91 melanoma cells.
Spanjaard RA; Ikeda M; Lee PJ; Charpentier B; Chin WW; Eberlein TJ
J Biol Chem; 1997 Jul; 272(30):18990-9. PubMed ID: 9228081
[TBL] [Abstract][Full Text] [Related]
23. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
[TBL] [Abstract][Full Text] [Related]
24. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
25. Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Hewson QC; Lovat PE; Pearson AD; Redfern CP
J Cell Biochem; 2002; 87(3):284-91. PubMed ID: 12397610
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
[TBL] [Abstract][Full Text] [Related]
27. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid-induced developmental defects are mediated by RARbeta/RXR heterodimers in the pharyngeal endoderm.
Matt N; Ghyselinck NB; Wendling O; Chambon P; Mark M
Development; 2003 May; 130(10):2083-93. PubMed ID: 12668623
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
[TBL] [Abstract][Full Text] [Related]
30. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
[TBL] [Abstract][Full Text] [Related]
31. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Lømo J; Smeland EB; Ulven S; Natarajan V; Blomhoff R; Gandhi U; Dawson MI; Blomhoff HK
J Cell Physiol; 1998 Apr; 175(1):68-77. PubMed ID: 9491782
[TBL] [Abstract][Full Text] [Related]
32. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation.
Johnson BS; Chandraratna RA; Heyman RA; Allegretto EA; Mueller L; Collins SJ
Mol Cell Biol; 1999 May; 19(5):3372-82. PubMed ID: 10207061
[TBL] [Abstract][Full Text] [Related]
33. Role of Ser(289) in RARgamma and its homologous amino acid residue of RARalpha and RARbeta in the binding of retinoic acid.
Zhang ZP; Shukri M; Gambone CJ; Gabriel JL; Soprano KJ; Soprano DR
Arch Biochem Biophys; 2000 Aug; 380(2):339-46. PubMed ID: 10933889
[TBL] [Abstract][Full Text] [Related]
34. Selective alteration of gene expression in response to natural and synthetic retinoids.
Brand C; Ségard P; Plouvier P; Formstecher P; Danzé PM; Lefebvre P
BMC Pharmacol; 2002 May; 2():13. PubMed ID: 12019025
[TBL] [Abstract][Full Text] [Related]
35. [Retinoid antagonists].
Umemiya H; Kagechika H; Fukasawa H; Hashimoto Y; Shudo K
Yakugaku Zasshi; 1996 Dec; 116(12):928-41. PubMed ID: 8993231
[TBL] [Abstract][Full Text] [Related]
36. Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid.
Konta T; Xu Q; Furusu A; Nakayama K; Kitamura M
J Biol Chem; 2001 Apr; 276(16):12697-701. PubMed ID: 11278809
[TBL] [Abstract][Full Text] [Related]
37. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway.
López-Boado YS; Klaus M; Dawson MI; López-Otín C
J Biol Chem; 1996 Dec; 271(50):32105-11. PubMed ID: 8943263
[TBL] [Abstract][Full Text] [Related]
38. Retinoids increase alpha-1 acid glycoprotein expression at the transcriptional level through two distinct DR1 retinoic acid responsive elements.
Mouthiers A; Mejdoubi N; Baillet A; Amélie PA; Porquet D
Biochim Biophys Acta; 2004 May; 1678(2-3):135-44. PubMed ID: 15157739
[TBL] [Abstract][Full Text] [Related]
39. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors.
Yang Y; Minucci S; Ozato K; Heyman RA; Ashwell JD
J Biol Chem; 1995 Aug; 270(31):18672-7. PubMed ID: 7629199
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
